Cart
sales@molnova.com
HNMPA
CAS No. 132541-52-7
HNMPA ( —— )
Catalog No. M27459 CAS No. 132541-52-7
HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 53 | Get Quote |
|
| 5MG | 77 | Get Quote |
|
| 10MG | 132 | Get Quote |
|
| 25MG | 285 | Get Quote |
|
| 50MG | 428 | Get Quote |
|
| 100MG | 626 | Get Quote |
|
| 500MG | 1323 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHNMPA
-
NoteResearch use only, not for human use.
-
Brief DescriptionHNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.
-
DescriptionHNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.(In Vitro):HNMPA reduces neuronal firing after GABA application and blocks GABA-dependent insulin inhibition. HNMPA has no effect on cyclic AMP-dependent protein kinase or protein kinase C activities.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorDNMT3B;Parasite;antimalarial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132541-52-7
-
Formula Weight238.2
-
Molecular FormulaC11H11O4P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=P(O)(O)C(O)C=1C=CC=2C=CC=CC2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tanaka Y, et al.Heme-dependent radical generation: possible involvement in antimalarial action of non-peroxide microbial metabolites, nanaomycin A and radicicol.J Antibiot (Tokyo). 1999 Oct;52(10):880-8.
molnova catalog
related products
-
PQ401
PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.
-
NVP-AEW541
NVP-AEW541 (AEW-541, AEW541) is a potent, and selective inhibitor of IGF-1R with IC50 of 86 nM.
-
NBI-31772
NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.
